Wörwag Pharma GmbH & Co. KG
Markus Pritschet is an experienced professional in regulatory affairs and pharmaceutical chemistry. Currently serving as Senior Manager of Regulatory Affairs at Wörwag Pharma GmbH & Co. KG, Markus previously held the position of Senior Lab Manager at Phytos from April 2008 to August 2016, focusing on the stability testing of pharmaceuticals. Prior experience includes serving as Head of Regulatory Affairs at Cefak KG, Kempten, from September 2001 to February 2008, and as an Applications Engineer at Prior Separation Technology in Götzis, Austria, between March 1999 and August 2001. Markus holds a degree in Pharmaceutical Chemistry (Dipl. Ing. Chemie (FH)) from Fachhochschule Isny, completed in 1999.
Wörwag Pharma GmbH & Co. KG
Woerwag Pharma GmbH & Co. KG is a family-owned and international operating pharmaceutical company headquartered in Boeblingen, Germany, developing and selling biofactor preparations wordwide with more than 1400 employees in 35 countries. The company’s product rage is exclusively available in pharmacies and includes both prescription preparations as well as over the counter (OTC) products and food supplements. Therapeutic areas focus on diabetic comorbidities, diseases of the nervous system, of the musculoskeletal system, as well as on stabilizing the immune system.